Did you know the U.S. accounts for over 40% of the global medical device market? đĄItâs a multi-billion-dollar industry driven by innovation, clinical excellence, and demand for quality healthcare solutions. Entering this highly regulated market can be challenging â from FDA 510(k) submissions to establishing local distribution networks, navigating the process alone can be complex. đ Thatâs where CMS SCiDoc comes in. We act as your trusted U.S. Local Representative, helping you:â Navigate FDA regulations & 510(k) submissionsâ Streamline market entryâ Build trust with stakeholdersâ Focus on innovation while we handle the groundwork đ Partner with CMS SCiDoc and unlock your pathway to success in the U.S. medical device market.[…]
Tag: TFDA
Are you a medical device manufacturer looking to expand to India?
Indiaâs healthcare landscape is undergoing a transformative expansion, making it one of the most promising frontiers for medical device innovation and growth. With a population exceeding 1.4 billion, and a healthcare market projected to reach USD 50 billion by 2030, India presents unparalleled opportunities for global manufacturers. đ Why Bring Your Medical Device to India?đ USD 50+ Billion Market by 2030đ 15%+ CAGR â among the fastest-growing global medical device marketsđ Growing private healthcare sector and rapid hospital expansionđ Rising demand for quality imported devices in imaging, surgery, diagnostics, cardiology, orthopedics, and home care Successfully entering the Indian market requires more than just exportingâit requires local insight, regulatory expertise, and strategic positioning.CMS SciDoc provides:â CDSCO Regulatory Strategy & Device Registrationâ Seamless navigation of Indian[…]
Unlock Access to Europeâs âŹ150+ Billion Medical Device Market.
The European Union is one of the worldâs largest and most highly regulated medical device markets, serving over 500 million consumers and generating more than âŹ150 billion annually. Achieving MDR or IVDR compliance is essential â but itâs only the first step. To legally place your device on the EU market, you must appoint a qualified EU-based Local Representative. At CMS SciDoc, we deliver reliable, fully compliant, and responsive EU Local Representative services tailored to:đ Medical Devices (MDR 2017/745)đ In Vitro Diagnostics (IVDR 2017/746)đ Software as a Medical Device (SaMD)đ Startups and Global Manufacturers With over 33% of global medtech revenue generated in Europe, the opportunity is significant. Our expertise ensures not only[…]
Cosmetics GMP for Export Purposes (ISO 22716) â Responsible Person
C | M | S can now act as your European responsible Person. If you are a cosmetics exporter, you may have had been notified by mandated bodies that you require to comply with EC Regulation 1223/2009. What are the requirements for this regulation? All cosmetic products exported to Europe/Asia/NZ will have to be produced according to Good Manufacturing Practices. Cosmetics Good Manufacturing Practices (GMP) is one of the pillars of the New European Regulation for Cosmetics. This regulation sets the requirements to ensure consumersâ safety. Amongst these new legal requirements, all cosmetic products circulating onto the European Market will have to be produced according to Good Manufacturing Practices; a Product Information[…]
Top Reasons to Choose Compliance Management Solutions as Your TGA Sponsor
Why Partner with Compliance Management Solutions as Your Australian TGA Sponsor Navigating Australiaâs Therapeutic Goods Administration (TGA) regulatory framework requires more than a local presenceâit demands regulatory expertise, responsiveness, and accountability. Compliance Management Solutions (CMS) provides medical device manufacturers with a reliable, experienced, and commercially pragmatic Australian TGA Sponsor solution. As your TGA Sponsor, CMS acts as a seamless extension of your regulatory team, supporting ARTG inclusion, ongoing compliance, post-market obligations, and direct regulatory liaison with the TGA. We ensure your devices are correctly classified, supported by appropriate conformity assessment evidence, and maintained in compliance throughout their lifecycle in Australia. CMS brings a strong understanding of both international regulatory frameworks[…]
MDR 2017/745 and IVDR 2017/746 EU Authorised Representative & EU Importer Services
Compliance Management Solutions Europe Medical device manufacturers seeking access to the European Union market must comply with the regulatory obligations of MDR (EU) 2017/745, including the appointment of a compliant EU Authorised Representative and, where applicable, an EU Importer. Compliance Management Solutions Europe provides integrated EU Rep and EU Importer services designed to support lawful market access, regulatory continuity, and post-market compliance. As an EU Authorised Representative, Compliance Management Solutions Europe fulfils the responsibilities outlined in Article 11 of the MDR, acting as the manufacturerâs official regulatory presence within the EU. We support manufacturers by verifying the availability and completeness of technical documentation and Declarations of Conformity, maintaining regulatory records,[…]
This New Year, invest in your professional growth and strengthen your regulatory knowledge to stay ahead in the dynamic world of medical devices.
CMS SciDoc invites Expressions of Interest for our Medical Device Training Programmes â 2026, designed to empower professionals with practical expertise and up-to-date insights into global regulatory requirements.Our programs are crafted and delivered by experienced medical device consultants, blending regulatory theory with real-world, hands-on application to help you achieve compliance confidence. Who should attend?đ Regulatory Affairs & Quality professionalsđ Medical device manufacturers & sponsorsđ Start-ups entering the medical device marketđ R&D, Clinical, QA/RA, and Compliance teams Proposed training topics:đ ISO 13485 â Quality Management Systems for Medical Devicesđ ISO 14971 â Risk Management for Medical Devicesđ Process Validation for Medical Devicesđ Medical Device Softwaređ Auditor Trainingđ Designing a Regulatory Compliant Technical Fileđ Clinical Evaluation Report: Tips & Tricksđ MDSAP[…]
FDA draft guidance for biocompatibility assessment
FDA published the draft guidance on chemical analysis for biocompatibility assessment of medical devices on September 20, 2024. This guidance provides recommendations for the collection and reporting of chemical characterization data that should be used to support medical device market clearance.
TGA proposed changes to the Regulation of Assistive Technologies
The new TGA document, Consultation: Proposed Changes to the Regulation of Assistive Technologies, seeks feedback on the current provisions in the Therapeutic Goods Determination 2018. These provisions classify âhousehold and personal aids, or furniture and utensils for people with disabilitiesâ as excluded goods, meaning they are regulated as consumer goods instead of therapeutic goods.
The EU Commission published AI Regulation EU – 2024/1689
The European Commission published AI Regulation EU – 2024/1689 to establish a uniform legal framework for the development, market placement, deployment, and use of artificial intelligence systems (AI systems) within the Union. Contact us to help you determine how this regulation works for your SaMD.